Skip to content
The Nexus
DossierENTITY

Incyte

Coverage of Incyte in the Nexus archive.

Earliest in view: Jun 8 · 12:40 UTCMost recent: Jun 8 · 12:40 UTC
Co-mentioned in this coverage
blood disorderstopic1mid-sized drug manufacturerstopic1Big Pharmatopic1
Recent coverage
  • BUSINESSJun 8 · 12:40 UTCFINANCIAL TIMES WORLD
    Incyte strikes up to $2bn deal for blood disorder biotech

    Incyte has agreed to a potential $2 billion deal for a biotech company specializing in blood disorders. Mid-sized drug manufacturers are enhancing their pipelines and increasing competition with major pharmaceutical companies.

Incyte · Dossier · The Nexus